Alphagan and Visual disturbance - a phase IV clinical study of FDA data

Summary:

Visual disturbance is reported as a side effect among people who take Alphagan (brimonidine tartrate), especially for people who are female, 60+ old, also take Xalatan, and have Erection problems.

The phase IV clinical study analyzes which people have Visual disturbance when taking Alphagan. It is created by eHealthMe based on reports of 9,802 people who have side effects when taking Alphagan from the FDA, and is updated regularly.

What is Alphagan?

Alphagan has active ingredients of brimonidine tartrate. It is often used in glaucoma. eHealthMe is studying from 9,981 Alphagan users. Check the latest studies of Alphagan.

What is Visual disturbance?

Visual disturbance is found to be associated with 676 drugs and 976 conditions by eHealthMe. Check the latest studies of Visual disturbance.

On Jul, 10, 2026

9,802 people reported to have side effects when taking Alphagan.
Among them, 44 people (0.45%) have Visual disturbance.

Could Alphagan cause Visual disturbance?

Among these 44 people:

What is the gender of people who have Visual disturbance when taking Alphagan? *

female: 56.82 %
male: 43.18 %

What is the age of people who have Visual disturbance when taking Alphagan? *

What are other drugs people take besides Alphagan? *

Xalatan: 13 people, 29.55%
Cosopt: 9 people, 20.45%
Lumigan: 7 people, 15.91%
Norvasc: 5 people, 11.36%
Timoptic: 4 people, 9.09%
Zocor: 3 people, 6.82%
Cardura: 2 people, 4.55%
Pred Forte: 2 people, 4.55%
Erythromycin: 2 people, 4.55%
Pilocarpine Hydrochloride: 2 people, 4.55%

What are other side effects people have besides Visual disturbance? *

Vision Blurred: 7 people, 15.91%
Vitreous Floaters (spots before the eyes): 6 people, 13.64%
Eye Pain: 6 people, 13.64%
Impaired Driving Ability: 5 people, 11.36%
Retinal Detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue): 5 people, 11.36%
Dry Mouth: 4 people, 9.09%
Miosis (constriction of the pupil of the eye, resulting from a normal response to an increase in light): 4 people, 9.09%
Cataract (clouding of the lens inside the eye): 4 people, 9.09%
Nearsightedness (difficulty in seeing the far objects): 3 people, 6.82%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 6.82%

What are the existing conditions these people have? *

High Blood Pressure: 2 people, 4.55%
Erection Problems: 2 people, 4.55%
Intraocular Pressure Increased: 1 person, 2.27%
Inflammation: 1 person, 2.27%
High Blood Cholesterol: 1 person, 2.27%
Herpes Zoster: 1 person, 2.27%
Eye Operation Complication: 1 person, 2.27%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 2.27%
Asthma: 1 person, 2.27%
Angiopathy (generic term for a disease of the blood vessels): 1 person, 2.27%

* Approximation only. Some reports may have incomplete information.

Do you take Alphagan and have Visual disturbance?

- Check whether Visual disturbance is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Alphagan:

Alphagan (9,981 reports)

Browse all side effects of Alphagan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual disturbance:

Visual disturbance (676 drugs)

Browse all the conditions that are associated with Visual disturbance:

Visual disturbance (976 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on brimonidine tartrate (the active ingredients of Alphagan) and Alphagan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.